HOME>HOME>About ASKA Pharmaceutical Holdings>Board Members and Corporate Officers

Board Members and Corporate Officers

Members of the Board of Director

(As of April 1, 2024)

President, Member of the Board of Directors, Representative Director

Takashi Yamaguchi

Date of birth: May 10, 1952

Apr. 1978 Joined Teikoku Hormone Mfg. Co., Ltd. (currently ASKA Pharmaceutical Co., Ltd.)
Dec. 1987 Member of the Board of Directors of Teikoku Hormone Mfg. Co., Ltd.
Jun. 1991 President, Member of the Board of Directors, Representative Director of Teikoku Hormone Mfg. Co., Ltd.
Apr. 2021 President, Member of the Board of Directors, Representative Director of the Company (to Present)
Jun. 2021 Member of the Board of Directors, Representative Director, Chairman of the Board of ASKA Pharmaceutical Co., Ltd. (to Present)

■Important Concurrent Holding of Positions
Member of the Board of Directors, Representative Director, Chairman of the Board of ASKA Pharmaceutical Co., Ltd.
■Shares held (As of March 31, 2023)
891 thousand shares
■Meeting body attended and attendance status (FY2022)
Board of Directors: 100% (16/16)
Group Nomination Committee: 100% (1/1)
Group Remuneration Committee: 100% (1/1)

Senior Managing Member of the Board of Directors, Representative Director

Atsushi Maruo

Date of birth: February 10, 1959

Apr. 1981 Joined The Mitsubishi Bank, Ltd. (currently MUFG Bank, Ltd.)
Apr. 2009 Tohoku Region Manager and Sendai Branch Manager of The Mitsubishi Bank, Ltd.
Oct. 2010 Corporate Officer of ASKA Pharmaceutical Co., Ltd.
Jun. 2011 Member of the Board of Directors, Executive Corporate Officer of ASKA Pharmaceutical Co., Ltd.
Jun. 2014 Senior Managing Member of the Board of Directors of ASKA Pharmaceutical Co., Ltd.
Jun. 2015 Member of the Board of Directors of ASKA Pharma Medical Co., Ltd.
Member of the Board of Directors of ASKA Animal Health Co., Ltd.
Jun. 2019 Senior Managing Member of the Board of Directors, Representative Director of ASKA Pharmaceutical Co., Ltd.
Apr. 2021 Member of the Board of Directors of the Company
Jun. 2021 Senior Managing Member of the Board of Directors, Representative Director of the Company
Jun. 2021 Member of the Board of Directors, Vice Chairman of the Board of ASKA Pharmaceutical Co., Ltd. (to Present)
Apr. 2023 Senior Managing Member of the Board of Directors, Representative Director, in charge of Sustainability of the Company (to Present)

■Important Concurrent Holding of Positions
Member of the Board of Directors, Vice Chairman of the Board of ASKA Pharmaceutical Co., Ltd.
■Shares held (As of March 31, 2023)
34 thousand shares
■Meeting body attended and attendance status (FY2022)
Board of Directors: 94% (15/16)
ESG Committee: 100% (2/2)
Group Compliance Promotion Committee: 100% (1/1)

Senior Managing Member of the Board of Directors, Representative Director

Sohta Yamaguchi

Date of birth: December 17, 1983

Apr. 2008 Joined Hitachi, Ltd.
May. 2011 Registered as a patent attorney
Feb. 2016 Joined ASKA Pharmaceutical Co., Ltd.
Jun. 2017 Member of the Board of Directors, Executive Corporate Officer, in charge of Innovative Drug Discovery of ASKA Pharmaceutical Co., Ltd.
Jun. 2019 Managing Member of the Board of Directors, in charge of Innovative Drug Discovery, Development, and Business Strategy of ASKA Pharmaceutical Co., Ltd.
Apr. 2020 Managing Member of the Board of Directors, in charge of Innovative Drug Discovery, Development, Business Development, and Medical Affairs of ASKA Pharmaceutical Co., Ltd.
Apr. 2021 Member of the Board of Directors of the Company
Jun. 2021 Senior Managing Member of the Board of Directors, Representative Director of the Company (to Present)
Jun. 2021 President, Member of the Board of Directors, Representative Director of ASKA Pharmaceutical Co., Ltd. (to Present)

■Important Concurrent Holding of Positions
President, Member of the Board of Directors, Representative Director of ASKA Pharmaceutical Co., Ltd.

■Shares held (As of March 31, 2023)
32 thousand shares
■Meeting body attended and attendance status (FY2022)
Board of Directors: 100% (16/16)
Group Nomination Committee: 100% (1/1)
Group Remuneration Committee: 100% (1/1)
ESG Committee: 50% (1/2)

Member of the Board of Directors, Executive Corporate Officer

Maiko Mori

Date of birth: April 20, 1964

Apr. 1987 Joined Teikoku Hormone Mfg. Co., Ltd. (currently ASKA Pharmaceutical Co., Ltd.)
Jun. 2011 Director of Pharmaceutical Information Department of ASKA Pharmaceutical Co., Ltd.
Jul. 2017 Director of Pharmaceutical Affairs Department of ASKA Pharmaceutical Co., Ltd.
Apr. 2020 Division Director of Quality & Safety Assurance Division of ASKA Pharmaceutical Co., Ltd.
Jun. 2020 Corporate Officer, Division Director of Quality & Safety Assurance Division of ASKA Pharmaceutical Co., Ltd.
Jun. 2022 Member of the Board of Directors, Executive Corporate Officer, Division Director of Quality & Safety Assurance Division of ASKA Pharmaceutical Co., Ltd. (to Present)
Jun. 2022 Member of the Board of Directors, Executive Corporate Officer of the Company (to Present)

■Important Concurrent Holding of Positions
Member of the Board of Directors, Executive Corporate Officer, Division Director of Quality & Safety Assurance Division of ASKA Pharmaceutical Co., Ltd.

■Shares held (As of March 31, 2023)
8 thousand shares
■Meeting body attended and attendance status (FY2022)
Board of Directors: 100% (11/11)
Group Compliance Promotion Committee: 100% (1/1)

Member of the Board of Directors, Executive Corporate Officer

Fumiyoshi Yamaguchi

Date of birth: November 3, 1986

Jul. 2011 Joined ASKA Pharmaceutical Co., Ltd.
Apr. 2019 Corporate Officer, in charge of New Business Development and Assistant Director of Healthcare Business Unit of ASKA Pharmaceutical Co., Ltd.
Jun. 2020 Corporate Officer, in charge of Special Appointments of ASKA Pharmaceutical Co., Ltd., Member of the Board of Directors of ASKA Animal Health Co., Ltd.
Jan. 2021 President, Member of the Board of Directors, Representative Director of ASKA Animal Health Co., Ltd. (to Present)
Jun. 2021 Corporate Officer of the Company
Jun. 2022 Member of the Board of Directors, Executive Corporate Officer of the Company (to Present)

■Important Concurrent Holding of Positions
President, Member of the Board of Directors, Representative Director of ASKA Animal Health Co., Ltd.
■Shares held (As of March 31, 2023)
6 thousand shares
■Meeting body attended and attendance status (FY2022)
Board of Directors: 100% (11/11)
ESG Committee: 100% (2/2)
Group Compliance Promotion Committee: 100% (1/1)

Member of the Board of Directors (Outside Director)

Yasunori Yoshimura

Date of birth: January 26, 1949

Apr. 1975 Joined the Department of Obstetrics and Gynecology, Keio University School of Medicine
Nov. 1995 Professor of the Department of Obstetrics and Gynecology, Keio University School of Medicine
Apr. 2007 Chairperson of Japan Society of Obstetrics and Gynecology
Jun. 2011 Member of the Board of Directors, Outside Director of ASKA Pharmaceutical Co., Ltd.
Oct. 2012 Representative Director of YOSHIMURA BIOETHIC INSTITUTE (to Present)
Nov. 2013 Outside Audit & Supervisory Board Member of Don Quijote Holdings Co., Ltd. (currently Pan Pacific International Holdings Corporation)
Apr. 2014 Professor Emeritus of Keio University (to Present)
Jul. 2015 Vice President of Fukushima Medical University
Sep. 2015 Outside Board Member (Audit & Supervisory Committee Member) of Don Quijote Holdings Co., Ltd. (currently Pan Pacific International Holdings Corporation) (to Present)
Apr. 2021 Member of the Board of Directors, Outside Director of the Company (to Present)

■Important Concurrent Holding of Positions
Representative Director of YOSHIMURA BIOETHIC INSTITUTE
Professor Emeritus of Keio University
Vice President of Fukushima Medical University
Outside Audit & Supervisory Board Member of Don Quijote Holdings Co., Ltd. (currently Pan Pacific International Holdings Corporation)

■Shares held (As of March 31, 2023)
-
■Meeting body attended and attendance status (FY2022)
Board of Directors: 100% (16/16)
Group Nomination Committee: 100% (1/1)
Group Remuneration Committee: 100% (1/1)

Member of the Board of Directors (Outside Director)

Minoru Awabayashi

Date of birth: December 19, 1952

Jul. 1978 Established Nihon Yo-Flow Co., Ltd. President and Representative Director
Jul. 1983 Established Pacific Marketing Partners, Inc. in the U.S. Managing Director
Jul. 1997 Established Omniglow Japan Co., Ltd. Vice President and Representative Director
Apr. 2005 President and Representative Director, Omniglow Japan Co., Ltd.
Apr. 2016 Senior Vice President, Takenaka Partners Corp. 
Jun. 2023 Member of the Board of Directors, Outside Director of the Company (to present)

■Important Concurrent Holding of Positions
-
■Shares held (As of March 31, 2023)
-
■Meeting body attended and attendance status (FY2022)
Board of Directors: - (newly appointed)

Member of the Board of Directors (Outside Director)

Yasuji Enokido

Date of birth: June 30, 1960

Apr. 1983 Joined Matsushita Electric Industrial Co. Ltd. (currently Panasonic Corporation)
Aug. 2007 President of Panasonic Avionics Corporation
Apr. 2013 Executive of Panasonic Corporation
Apr. 2015 Managing Executive Officer of Panasonic Corporation, President of AVC Networks Company
Jun. 2015 Managing Director of Panasonic Corporation
Apr. 2016 Representative Director and Senior Managing Director of Panasonic Corporation
Nov. 2017 Representative Director and President of Soen Co., Ltd. (to Present)
Jun. 2023 Member of the Board of Directors, Outside Director of the Company (to present)

■Important Concurrent Holding of Positions
Representative Director and President of Soen Co., Ltd.
■Shares held (As of March 31, 2023)
-
■Meeting body attended and attendance status (FY2022)
Board of Directors: - (newly appointed)

Audit & Supervisory Board Members

(As of June 27, 2023)

Audit & Supervisory Board Member

Ikuo Kumano

Date of birth: June 9, 1957

Apr. 1982 Joined Teikoku Hormone Mfg. Co., Ltd. (currently ASKA Pharmaceutical Co., Ltd.)
Jun. 2005 Director of Sales Planning Promotion Department of Teikoku Hormone Mfg. Co., Ltd.
Apr. 2006 Chugoku Branch Manager of ASKA Pharmaceutical Co., Ltd.
Oct. 2007 Fukuoka Branch Manager of ASKA Pharmaceutical Co., Ltd.
Apr. 2012 Director of Corporate Planning Unit of ASKA Pharmaceutical Co., Ltd.
Jun. 2014 Corporate Officer, in charge of Corporate Planning of ASKA Pharmaceutical Co., Ltd.
Apr. 2015 Corporate Officer of ASKA Pharmaceutical Co., Ltd., President and Representative Director of ASKA Pharma Medical Co., Ltd.
Jun. 2016 Corporate Officer, Division Director of Production Division of ASKA Pharmaceutical Co., Ltd.
Jun. 2018 Member of the Board of Directors, Executive Corporate Officer, in charge of Production, Division Director of Administrative
Jun. 2019 Division of ASKA Pharmaceutical Co., Ltd. Member of the Board of Directors, Executive Corporate Officer, Division Director of Administrative Division and Director of 100th Anniversary Business Unit of ASKA Pharmaceutical Co., Ltd.
Apr. 2021 Member of the Board of Directors of the Company
Jun. 2021 Audit & Supervisory Board Member of the Company (to Present)
Jun. 2021 Audit & Supervisory Board Member of ASKA Animal Health Co., Ltd. (to Present)

■Important Concurrent Holding of Positions
Audit & Supervisory Board Member of ASKA Animal Health Co., Ltd. ■Shares held (As of March 31, 2023)
8 thousand shares
■Meeting body attended and attendance status (FY2022)
Board of Directors: 100% (16/16)
Audit & Supervisory Board: 100% (16/16)

Audit & Supervisory Board Member

Yuichiro Fukui

Date of birth: August 4, 1959

Apr. 1984 Joined Takeda Pharmaceutical Company Limited
Apr. 2009 Director of Eastern Japan Sales Unit of Pharmaceutical Marketing Division of Takeda Pharmaceutical Company Limited
Jun. 2015 Executive Corporate Officer of ASKA Pharmaceutical Co., Ltd.
Jun. 2016 Member of the Board of Directors, Executive Corporate Officer, supervising Sales Management, Division Director of Marketing Division of ASKA Pharmaceutical Co., Ltd.
Apr. 2017 Member of the Board of Directors, Executive Corporate Officer, supervising Sales Management of ASKA Pharmaceutical Co., Ltd.
Apr. 2021 Member of the Board of Directors of the Company
Jun. 2021 Audit & Supervisory Board Member of the Company (to Present)
Jun. 2021 Audit & Supervisory Board Member of ASKA Pharmaceutical Co., Ltd. (to Present)

■Important Concurrent Holding of Positions
Audit & Supervisory Board Member of ASKA Pharmaceutical Co., Ltd. ■Shares held (As of March 31, 2023)
12 thousand shares
■Meeting body attended and attendance status (FY2022)
Board of Directors: 100% (16/16)
Audit & Supervisory Board: 100% (16/16)

Outside Audit & Supervisory Board Member

Takao Kimura

Date of birth: August 9, 1951

Nov. 1975 Joined Hoechst Japan Ltd. (currently Sanofi K.K.)
Jul. 2000 President and Representative Director of Nycomed Amersham PLC
Dec. 2002 Executive Officer, General Manager of Business Development Division of Aventis Pharma Limited (currently Sanofi K.K.)
Apr. 2010 Executive Officer, Supervising Manager of Business Development Division in Asia-Pacific Region of Sanofi-aventis K.K. (currently Sanofi K.K.)
Feb. 2016 Representative Partner of TK Pharma Partners LLC. (to Present)
Jun. 2017 Outside Audit & Supervisory Board Member of ASKA Pharmaceutical Co., Ltd.
Apr. 2021 Outside Audit & Supervisory Board Member of the Company (to Present)

■Important Concurrent Holding of Positions
Representative Partner of TK Pharma Partners LLC.
■Shares held (As of March 31, 2023)
-
■Meeting body attended and attendance status (FY2022)
Board of Directors: 100% (16/16)
Audit & Supervisory Board: 100% (16/16)
Group Nomination Committee: 100% (1/1)
Group Remuneration Committee: 100% (1/1)

Outside Audit & Supervisory Board Member

Keiko Fukuchi

Date of birth: January 7, 1959

Apr. 1981 Joined Tokyo Regional Taxation Bureau
Jul. 2006 Deputy District Director of Shibuya Tax Office
Jul. 2008 Professor of National Tax College
Jul. 2013 Director (Mutual Agreement Procedures), International Operations Division, Commissioner’s Secretariat of National Tax Agency
Mar. 2018 Regional Commissioner of Kanazawa Regional Taxation Bureau
Aug. 2019 Registered as a tax accountant. Representative of Fukuchi Keiko Tax Accountant Office (to Present)
Jun. 2020 Outside Audit & Supervisory Board Member of ASKA Pharmaceutical Co., Ltd.
Jun. 2020 Outside Director (Audit and Supervisory Committee Member) of KAWADA TECHNOLOGIES, INC. (to Present)
Jun. 2020 Outside Auditor of KAWADA INDUSTRIES, INC. (to Present)
Apr. 2021 Outside Audit & Supervisory Board Member of the Company (to Present)

■Important Concurrent Holding of Positions
Representative of Fukuchi Keiko Tax Accountant Office
Outside Director (Audit and Supervisory Committee Member) of KAWADA TECHNOLOGIES, INC.
Outside Auditor of KAWADA INDUSTRIES, INC.
■Shares held (As of March 31, 2023)
-
■Meeting body attended and attendance status (FY2022)
Board of Directors: 100% (16/16)
Audit & Supervisory Board: 100% (16/16)
Group Nomination Committee: 100% (1/1)
Group Remuneration Committee: 100% (1/1)

Corporate Officers

(As of April 1, 2024)

Kiyohiko Tamura Executive Corporate Officer Division Director, Group Business Management Division
In Charge of DX Promotion
(Executive Corporate Officer, Division Director, Administrative Division of ASKA Pharmaceutical Co., Ltd.)
(Member of the Board of Directors of ASKA Animal Health Co., Ltd.)
(Member of the Board of Directors of ASKA Pharma Medical Co., Ltd.)
Kunihiro Gunji Corporate Officer In Charge of Audit and Legal Affairs & Regulatory Compliance
(Corporate Officer, Director of Information service Supervisory Unit of ASKA Pharmaceutical Co., Ltd.)
Junichi Saito Corporate Officer (President, Member of the Board of Directors, Representative Director of ASKA Pharma Medical Co., Ltd.)